Keyphrases
Induced Pluripotent Stem Cells (iPSCs)
100%
Induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells
100%
Adriamycin-induced Nephropathy
100%
B-cell Lymphoma 2 (Bcl-2)
28%
Tubular Cells
28%
Lung
14%
Survivin
14%
Reduced Expression
14%
Oxidative Stress
14%
Antifibrotic
14%
Intravenous Injection
14%
Albumin
14%
Conditioned Medium
14%
Intrarenal
14%
Survivin Expression
14%
Kidney Disease
14%
Hedgehog Signaling Pathway
14%
Collagen I
14%
Anti-apoptosis
14%
Tubulointerstitial Fibrosis
14%
Renal Function Decline
14%
Cell-Associated
14%
Beneficial Role
14%
Collagen IV
14%
Repeated Injection
14%
Cell Replacement Therapy
14%
Tubular Apoptosis
14%
Long-term Modelling
14%
Medicine and Dentistry
Mesenchymal Stem Cell
100%
Adriamycin-Induced Nephropathy
100%
Induced Pluripotent Stem Cell
100%
Survivin
28%
In Vitro
14%
Upregulation
14%
Antiapoptotic
14%
Kidney Function
14%
Downregulation
14%
Fibrosis
14%
Programmed Cell Death
14%
Oxidative Stress
14%
Cell Signaling Pathway
14%
Hedgehog Signaling
14%
Cell Replacement Therapy
14%
Kidney Disorder
14%
Lung
14%
Albumin
14%
Intravenous Injection
14%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
Doxorubicin
100%
Human Induced Pluripotent Stem Cell
100%
Survivin
28%
Upregulation
14%
Induced Pluripotent Stem Cell
14%
Downregulation
14%
Kidney Function
14%
Oxidative Stress
14%
Hedgehog Signaling Pathway
14%
Programmed Cell Death
14%
Albumin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adriamycin-Induced Nephropathy
100%
Survivin
28%
Antiapoptotic
14%
Fibrosis
14%
Replacement Therapy
14%
Kidney Disease
14%
Hedgehog
14%
Albumin
14%